New multiple myeloma drug shows promise in treating people with advanced disease
A new oral agent under review by the U.S. Food and Drug Administration (FDA) is safe and effective in treating relapsed and treatment-resistant multiple myeloma, according to a multicenter, Phase II study presented by Mount ...
Dec 10, 2012
0
0